Calluna Pharma is a startup based in Norway, most recent round Series A, 1 tracked investor.
Calluna Pharma is a startup founded in 2020 based in Norway. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Calluna Pharma is a clinical-stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases by targeting upstream innate immune amplifiers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.